Effect of osteopathic manipulative treatment on gastrointestinal function and length of stay of preterm infants: an

Gianfranco Pizzolorusso1, Patrizia Turi, Gina Barlafante

  • 1EBOM - European Institute for Evidence Based Osteopathic Medicine, viale Unità d'Italia 1, 66100 Chieti, Italy. gianfranco.pizzolorusso@gmail.com.

Insights

Osteopathic manipulative treatment may reduce gastrointestinal symptoms and length of stay for premature infants in the neonatal intensive care unit (NICU). Further randomized controlled studies are needed for broader application.

Area of Science:

  • Neonatal care
  • Osteopathic medicine
  • Pediatric gastroenterology

Background:

  • Neonatal intensive care units (NICUs) require monitoring of preterm infants' gastrointestinal function.
  • Optimizing discharge timing is crucial for organizational improvement in NICUs.

Purpose of the Study:

  • To investigate the effect of osteopathic manipulative treatment (OMT) on premature infants in the NICU.
  • To assess OMT's impact on length of stay and gastrointestinal symptoms.

Main Methods:

  • Prospective study of 350 premature infants in a NICU.
  • Comparison between a group receiving OMT and a control group receiving standard care.
  • Analysis of excessive length of stay and gastrointestinal symptoms using logistic regression.

Main Results:

  • OMT was associated with a reduced risk of significant gastrointestinal symptoms (OR = 0.45).
  • OMT significantly reduced the risk of extended length of stay (≥28 days) in the NICU (OR = 0.22).
  • Factors like lower gestational age and birth weight were linked to longer stays, but OMT mitigated this risk.

Conclusions:

  • Osteopathic manipulative treatment demonstrated potential in reducing gastrointestinal issues and prolonged stays for premature infants in the NICU.
  • Further randomized controlled trials are necessary to validate these findings for a wider high-risk newborn population.
Abstract

Related Concept Videos

Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...